Navigation Links
Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C
Date:11/2/2007

Data to be Presented at AASLD Meeting

TAMPA, Fla., Nov. 2 /PRNewswire/ -- Romark Laboratories, a privately-owned biotechnology company, today announced results of a randomized phase II clinical trial showing that 79% of interferon-naive patients with chronic hepatitis C genotype 4 receiving nitazoxanide plus the standard of care had a sustained virologic response (SVR), or undetectable level of virus, 12 weeks following treatment, compared to 43% of patients receiving the standard of care without nitazoxanide. The patients treated with nitazoxanide also experienced no relapse and no more side effects than patients who received the standard of care. Interim results from this Phase II clinical trial will be presented on Tuesday November 6 in an oral presentation at the 58th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston.

"Patients treated with nitazoxanide responded earlier and maintained their responses without relapse after receiving only 36 weeks of treatment with peginterferon and ribavirin," said Dr. Emmet B. Keeffe, Chief of Hepatology at Stanford University School of Medicine. "These data suggest the emergence of a new therapeutic approach for treating hepatitis C. While more study is needed to confirm these results in a broader population of patients, nitazoxanide appears to increase the potency of interferon without increasing toxicity or inducing resistance."

Study Details

This Phase II randomized, controlled trial was conducted at two centers in Egypt and is part of the company's STEALTH C (Studies to Evaluate Alinia for Treatment of Hepatitis C) clinical development program, which is designed to evaluate the safety and efficacy of nitazoxanide tablets in combination with peginterferon or peginterferon and ribavirin (standard of care) in patients with chronic hepatitis C.

In the trial, 96 treatment-naive patients with chronic hepatitis C genotype 4 were random
'/>"/>

SOURCE Romark Laboratories
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. FDA approves Phase 0 trial which tests experimental drugs on humans
2. SARS-Free Taiwan to Mark End Phase of Global Fight
3. S. Africa AIDS in death phase
4. Spray on contraceptive clears Phase I trial
5. Phase 3 trials of two multi-kinase inhibitors against cancer
6. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
7. Phase II trails of new HIV vaccine to be held in South Africa
8. Phase 1 Drug Trials on Humans to Be Made Public
9. Jalgaon: Third Phase Of Culling Operations Begin
10. Lupin Gets DCGI Nod For Phase II Clinical Trials On Desoside-P
11. Cadila to Commence Phase I Clinical Trials On ZYH2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... JZ Fitness, an independently operated wellness brand ... authorship, international lecturing and community wellness, created by Jenn ... of the JZ Fitness nutrition app, available on iTunes. ... of individuals on nutrition, Jenn Zerling (“JZ”) has developed ... calorie counting or cumbersome food logging. , ...
(Date:10/20/2014)... 20, 2014 AttorneyOne.com, a recognized authority on ... from the FDA on Sit and Slim II . ... to purchase or use Sit and Slim II because it ... is promoted as weight loss product on various websites and ... market in 2010 for safety reasons, can significantly increase blood ...
(Date:10/20/2014)... 20, 2014 Succeed is proud to announce ... who participated in the Every Body Walk! campaign ... awareness project that encourages workers to be more active outside ... Program, which concluded at the end of September, was a ... and metro areas. Participating companies gave their staff pedometers ...
(Date:10/20/2014)... California (PRWEB) October 20, 2014 Final Cut ... the release of the Citrus theme for FCPX filmmakers ... would use to describe the Citrus theme” Says Christina Austin, ... easy to look so professional.” , Citrus comes with all ... with the template are: four transitions for added style, a ...
(Date:10/20/2014)... New York, NY (PRWEB) October 20, 2014 ... to be introduced in the U.S., has a lot to ... time when our country recognizes the achievements and contributions of ... marks the anniversary for Punzoné, and today it shares its ... and take a trip to Italy - even if it ...
Breaking Medicine News(10 mins):Health News:JZ Fitness Nutrition App Launches on iTunes 2Health News:JZ Fitness Nutrition App Launches on iTunes 3Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 4
... University of Phoenix has ... Florida Chapter , which will involve fundraising and volunteer ... 25. Additionally, the University is offering four full-tuition scholarships ... or a Master of Science in Nursing, demonstrating its ongoing ...
... RIVER, Mass., April 20 Millstone Medical Outsourcing announced today ... River, MA. Millstone will hold an Open House on ... state and local dignitaries, and friends of the company. ... scheduled to attend. Massachusetts Governor Deval Patrick and Senator ...
... and Israel has identified a genetic variation that influences ... finding is published in the latest edition of the ... Leonard, who heads the Australian Rett Syndrome Study at ... finding was exciting in that it identifies a potential ...
... ability to use objects and tools to perform actions is ... a level that is unique to our species. In a ... Center for Scientific Research (CNRS) and the Paris Descartes University, ... Cortex ( www.elsevier.com/locate/cortex ), researchers have found that brain-lesioned ...
... newly developed technique for the curative treatment of high-grade ... especially to elderly, multimorbid patients for whom the risk ... initial results obtained with this technique at the German ... issue of Deutsches rzteblatt International by Sabine ...
... To Transmit Electronic Claims Through Availity At No ... industry,s premier health information network, today announced it ... claims clearinghouse by Mid Rogue Health Plan, an ... Grants Pass, Oregon. After a successful implementation, Availity ...
Cached Medicine News:Health News:University of Phoenix Announces March of Dimes Partnership in Florida, Offers Four Full-Tuition Nursing Scholarships 2Health News:University of Phoenix Announces March of Dimes Partnership in Florida, Offers Four Full-Tuition Nursing Scholarships 3Health News:Millstone Medical Outsourcing Celebrates New Fall River Facility, Designed to Meet Demand for Advanced Inspection, Clean Room Services 2Health News:New insight into Rett syndrome severity 2Health News:Valve implantation on the beating heart 2Health News:Mid Rogue Health Plan Implements Availity as Its Designated Clearinghouse 2
(Date:10/17/2014)... -- Talyst, a market leader in pharmacy automation will be ... Nashville, TN. The company will be ... onsite, remote medication dispensing. Talyst,s InSite ... securely dispense medication onsite, on demand. Remote dispensing cuts ... the correct medication gets to the correct patient in ...
(Date:10/17/2014)... 2014  Ameritox SM , the nation,s leader in ... Thomas Smith , M.D., as Chief Medical Officer. In ... scientific resources for healthcare providers, patients and managed care ... at a variety of healthcare companies that have provided ... and behavioral health sides of Ameritox,s business. He most ...
(Date:10/17/2014)... Oct. 17, 2014   DaVita HealthCare Partners ... of the nation,s largest and most innovative health ... Academy – the company,s award-winning, leadership development and ... DaVita teammates from around the globe were in ... University Academy is a two-day one-of-a-kind experience for ...
Breaking Medicine Technology:Talyst Exhibits at LeadingAge Annual Meeting 2Ameritox Appoints New Chief Medical Officer 2DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 2DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 3
... 12, 2011 Chartwell Pharmaceuticals announced that effective March ... with the Federal Drug Administration agency. The registration, filed ... which is in the process of executing a successful ... Chartwell,s Senior Director of Quality and Regulatory, ...
... Boston Scientific Corporation (NYSE: BSX ) has ... study designed to evaluate its Adapt™ Monorail™ Carotid Stent ... System for treatment of carotid artery disease in patients ... in 2010 and has reached its enrollment goal of ...
Cached Medicine Technology:Boston Scientific Completes Clinical Trial Enrollment for Adapt™ Monorail™ Carotid Stent System 2Boston Scientific Completes Clinical Trial Enrollment for Adapt™ Monorail™ Carotid Stent System 3Boston Scientific Completes Clinical Trial Enrollment for Adapt™ Monorail™ Carotid Stent System 4
... Portex® Blue Line ULTRA® Suctionaid® tracheostomy tubes ... removal of secretions from above the tracheostomy ... ULTRA® Suctionaid® tracheostomy tubes provide an additional ... from above the tracheostomy tube cuff helping ...
Manufactured form the same soft siliconized PVC as all Portex® Blue Line® tracheostomy tubes....
... For additional patient safety, ... with an integral 15 mm ... connected to a ventilator, with ... in place , ,Portex® ...
... When the all silicone cuff ... no distinguishable dimension to the ... shaft, yet it can be ... varied airway management needs. TTS™ ...
Medicine Products: